Reprogramming of Cellular Metabolism and Its Therapeutic Applications in Thyroid Cancer

被引:11
|
作者
Nagayama, Yuji [1 ]
Hamada, Koichiro [1 ,2 ]
机构
[1] Nagasaki Univ, Atom Bomb Dis Inst, Dept Mol Med, 1-12-4 Sakamoto, Nagasaki 8528523, Japan
[2] Nagasaki Univ, Dept Gen Med, Grad Sch Biomed Sci, Nagasaki 8528501, Japan
关键词
thyroid cancer; metabolomics; the Warburg effect; glycolysis; TCA cycle; electron transport chain; lipid metabolism; glutaminolysis; BRAF V600E MUTATION; FATTY-ACID SYNTHASE; HURTHLE CELL; COMPLEX-I; GLUTAMINE-METABOLISM; MITOCHONDRIAL-DNA; TRANSPORTER EXPRESSION; GLUCOSE-METABOLISM; CARCINOMA; GLUCOSE-TRANSPORTER-1;
D O I
10.3390/metabo12121214
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolism is a series of life-sustaining chemical reactions in organisms, providing energy required for cellular processes and building blocks for cellular constituents of proteins, lipids, carbohydrates and nucleic acids. Cancer cells frequently reprogram their metabolic behaviors to adapt their rapid proliferation and altered tumor microenvironments. Not only aerobic glycolysis (also termed the Warburg effect) but also altered mitochondrial metabolism, amino acid metabolism and lipid metabolism play important roles for cancer growth and aggressiveness. Thus, the mechanistic elucidation of these metabolic changes is invaluable for understanding the pathogenesis of cancers and developing novel metabolism-targeted therapies. In this review article, we first provide an overview of essential metabolic mechanisms, and then summarize the recent findings of metabolic reprogramming and the recent reports of metabolism-targeted therapies for thyroid cancer.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy
    Wan, Yuxuan
    Li, Guoqing
    Cui, Gaoyuan
    Duan, Saili
    Chang, Shi
    MOLECULAR CANCER, 2025, 24 (01)
  • [2] Cellular Reprogramming as a Therapeutic Target in Cancer
    Xiong, Shumin
    Feng, Ye
    Cheng, Lin
    TRENDS IN CELL BIOLOGY, 2019, 29 (08) : 623 - 634
  • [3] Editorial: Hallmark of cancer: Reprogramming of cellular metabolism
    Kaur, Baljinder
    Sohrabi, Yahya
    Achreja, Abhinav
    Lisanti, Michael P.
    Martinez-Outschoorn, Ubaldo Emilio
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [4] Vasculogenesis and Its Cellular Therapeutic Applications
    Ratajska, Anna
    Jankowska-Steifer, Ewa
    Czarnowska, Elzbieta
    Olkowski, Radoslaw
    Gula, Grzegorz
    Niderla-Bielinska, Justyna
    Flaht-Zabost, Aleksandra
    Jasinska, Agnieszka
    CELLS TISSUES ORGANS, 2017, 203 (03) : 141 - 152
  • [5] THERAPEUTIC CLONING AND CELLULAR REPROGRAMMING
    Rodriguez, Ramon M.
    Ross, Pablo J.
    Cibelli, Jose B.
    STEM CELL TRANSPLANTATION, 2012, 741 : 276 - 289
  • [6] Metabolic reprogramming and its clinical application in thyroid cancer
    Wen, Shi-Shuai
    Zhang, Ting-Ting
    Xue, Di-Xin
    Wu, Wei-Li
    Wang, Yu-Long
    Wang, Yu
    Ji, Qing-Hai
    Zhu, Yong-Xue
    Qu, Ning
    Shi, Rong-Liang
    ONCOLOGY LETTERS, 2019, 18 (02) : 1579 - 1584
  • [7] Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
    Gandhi, Nishant
    Das, Gokul M.
    CELLS, 2019, 8 (02)
  • [8] Lipid metabolism reprogramming and its potential targets in cancer
    Cheng, Chunming
    Geng, Feng
    Cheng, Xiang
    Guo, Deliang
    CANCER COMMUNICATIONS, 2018, 38
  • [9] Reprogramming of glucose metabolism of cumulus cells and oocytes and its therapeutic significance
    Imanaka, Shogo
    Shigetomi, Hiroshi
    Kobayashi, Hiroshi
    REPRODUCTIVE SCIENCES, 2022, 29 (03) : 653 - 667
  • [10] Reprogramming of glucose metabolism of cumulus cells and oocytes and its therapeutic significance
    Shogo Imanaka
    Hiroshi Shigetomi
    Hiroshi Kobayashi
    Reproductive Sciences, 2022, 29 : 653 - 667